Related references
Note: Only part of the references are listed.Age-related memory deficits are associated with changes in protein degradation in brain regions critical for trace fear conditioning
Brooke N. Dulka et al.
NEUROBIOLOGY OF AGING (2020)
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
Eduardo P. De Mattos et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
Yasushi Yabuki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia
Ichiro Kawahata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in AppNL-G-F/NL-G-F Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling
Hisanao Izumi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice
Hidaka Haga et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway
Yasushi Yabuki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice
Jing Xu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in &ITApp&IT Knock-in Mice
Hisanao Izumi et al.
NEUROSCIENCE (2018)
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Tiffany A. Thibaudeau et al.
NATURE COMMUNICATIONS (2018)
The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins
Olga Buneeva et al.
CELLS (2018)
Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
Amani Alghamdi et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin et al.
JOURNAL OF NEUROSCIENCE (2017)
Pharmacological properties of SAK3, a novel T-type voltage-gated Ca2+ channel enhancer
Yasushi Yabuki et al.
NEUROPHARMACOLOGY (2017)
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Sebastian Palmqvist et al.
NATURE COMMUNICATIONS (2017)
The Proteasome Inhibition Model of Parkinson's Disease
Eduard Bentea et al.
JOURNAL OF PARKINSONS DISEASE (2017)
The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology
Destiny-Love Manecka et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Danger: High Voltage-The Role of Voltage-Gated Calcium Channels in Central Nervous System Pathology
Andrea Schampel et al.
CELLS (2017)
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
Katrina L. Paumier et al.
NEUROBIOLOGY OF DISEASE (2015)
Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties
Iulia Blesneac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Low threshold T-type calcium channels as targets for novel epilepsy treatments
Kim L. Powell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates
Laura A. Volpicelli-Daley et al.
NATURE PROTOCOLS (2014)
NOBILETIN TREATMENT IMPROVES MOTOR AND COGNITIVE DEFICITS SEEN IN MPTP-INDUCED PARKINSON MODEL MICE
Y. Yabuki et al.
NEUROSCIENCE (2014)
The many faces of T-type calcium channels
Regis C. Lambert et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Poly-Ub-Substrate-Degradative Activity of 26S Proteasome Is Not Impaired in the Aging Rat Brain
Carolin Giannini et al.
PLOS ONE (2013)
CaMKII, but not protein kinase A, regulates Rpt6 phosphorylation and proteasome activity during the formation of long-term memories
Timothy J. Jarome et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
Activity-Dependent Growth of New Dendritic Spines Is Regulated by the Proteasome
Andrew M. Hamilton et al.
NEURON (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Distinct Roles In Vivo for the Ubiquitin-Proteasome System and the Autophagy-Lysosomal Pathway in the Degradation of α-Synuclein
Darius Ebrahimi-Fakhari et al.
JOURNAL OF NEUROSCIENCE (2011)
Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation
Lise Giehm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells
Ichiro Kawahata et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2009)
Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP+-elicited apoptosis
Yue-Fa Cheng et al.
NEUROSCIENCE RESEARCH (2009)
Striatal 19S Rpt6 deficit is related to α-synuclein accumulation in MPTP-treated mice
Bin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Pathological biochemistry of α-synucleinopathy
Takeshi Iwatsubo
NEUROPATHOLOGY (2007)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
The role of T-type calcium channels in epilepsy and pain
M. T. Nelson et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Proteasomes and their kin: Proteases in the machine age
CM Pickart et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
KSP McNaught et al.
ANNALS OF NEUROLOGY (2004)
The role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease
M Hashimoto et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression
AD Hope et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Aggregated and monomeric α-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function
H Snyder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
The molecular basis of CaMKII function in synaptic and behavioural memory
J Lisman et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death
L Stefanis et al.
JOURNAL OF NEUROSCIENCE (2001)
Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death
FMS De Vrij et al.
FASEB JOURNAL (2001)
Proteasomal function is impaired in substantia nigra in Parkinson's disease
KSP McNaught et al.
NEUROSCIENCE LETTERS (2001)
Structural basis for the activation of 20S proteasomes by 11S regulators
FG Whitby et al.
NATURE (2000)
α-synuclein promotes mitochondrial deficit and oxidative stress
LJ Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
